Molecular Imaging: Page 309

GE touts flutemetamol study results

By AuntMinnie.com staff writers

GE Healthcare is touting the results of two studies that suggest the company's investigational imaging agent F-18 flutemetamol could combine with other diagnostic tools to evaluate neurodegenerative conditions such as Alzheimer's disease.

January 16, 2012

Positron acquires Manhattan Isotope

By AuntMinnie.com staff writers

Molecular imaging developer Positron has completed its acquisition of Manhattan Isotope Technology.

January 16, 2012

FDA: User error caused CardioGen-82 mishaps

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration has confirmed that the "improper usage" of Bracco Diagnostics' CardioGen-82 cardiac PET radiopharmaceutical caused three patients from two different facilities to have increased levels of radiation in their bodies following PET scans.

January 16, 2012

Noninvasive imaging drives cardiac growth

By AuntMinnie.com staff writers

Cardiologists have substantially increased their billing for services over the past decade, but nearly all of the growth has been in noninvasive procedures, such as noninvasive imaging using CT, MRI, and ultrasound, according to a study published online January 10 in Circulation: Cardiovascular Quality and Outcomes.

January 15, 2012

Bayer's Trudeau to lead Covidien pharma unit

By AuntMinnie.com staff writers

Healthcare technology firm Covidien has appointed Mark Trudeau as president of its pharmaceuticals segment and a senior vice president of the company, effective February 1.

January 15, 2012

BSGI helps detect more breast cancer, alter treatment

By Wayne Forrest

Breast-specific gamma imaging (BSGI) confirmed mammography, ultrasound, and MRI results in 55% of patients and identified additional malignant lesions, clarified ambiguous findings, or significantly changed patient management in 20% of cases, according to a study from California researchers.

January 12, 2012